Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 tanezumab study in adults with chronic low back pain
2012-005495-34Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tanezumab in chronic low back pain (CLBP), sponsored by Pfizer. Started Sep 2015; status: completed.
02
Drugs
tanezumab
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2012-005495-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005495-34.